Japan to hold off on using AstraZeneca COVID-19 vaccine - media

JCR Pharmaceuticals

21/05/2021 02:32

TOKYO, May 21 (Reuters) - Japan is likely to hold off on
administering AstraZeneca PLC's  AZN.L  COVID-19 vaccine despite
expected approval on Friday, amid concerns about blood clots,
public broadcaster NHK and other media reported.
    The government it also expected to formally approve on
Friday the COVID-19 vaccine developed by Moderna Inc  MRNA.O  as
it seeks to speed up what has been the slowest vaccination
campaign among rich countries.  urn:newsml:reuters.com:*:nL2N2N70I1 

 (Reporting by Chang-Ran Kim; Editing by Jacqueline Wong)
 ((ran.kim@thomsonreuters.com; +81-3-4520-1228))